We are live on
!
Find out more
JAG
Journey Advisory Group Portfolio holdings
AUM
$1.31B
1-Year Est. Return
24.92%
This Fund
S&P 500
This Quarter
Est. Return
+11.1%
1 Year Est. Return
+24.92%
3 Year Est. Return
+66.16%
5 Year Est. Return
+83.95%
10 Year Est. Return
–
AUM
$362M
AUM Growth
+$53.3M
(+17%)
Cap. Flow
+$21.6M
Cap. Flow
% of AUM
5.97%
Top 10 Holdings %
Top 10 Hldgs %
35.88%
Holding
211
New
15
Increased
113
Reduced
50
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.57M |
| 2 |
Vanguard Total Bond Market
BND
|
+$961K |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$861K |
| 4 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$844K |
| 5 |
Accenture
ACN
|
+$823K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COR
Coresite Realty Corporation
COR
|
+$1.73M |
| 2 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$834K |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$388K |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$276K |
| 5 |
Medtronic
MDT
|
+$253K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.2% |
| 2 | Healthcare | 10.86% |
| 3 | Consumer Staples | 8.33% |
| 4 | Financials | 7.74% |
| 5 | Industrials | 5.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Boston Scientific
BSX
$74.2B
| $212K | 0.06% |
5,000
| – | – |
|
202
Medpace
MEDP
$16.9B
| $212K | 0.06% |
+975
| New | +$204K |
|
203
CME Group
CME
$93.2B
| $208K | 0.06% |
+912
| New | +$201K |
|
204
Invesco Ultra Short Duration ETF
GSY
$3.88B
| $207K | 0.06% |
4,110
| – | – |
|
205
Baxter International
BAX
$14.3B
| $202K | 0.06% |
+2,350
| New | +$189K |
|
206
Schwab US Large- Cap ETF
SCHX
$74.3B
| $201K | 0.06% |
+10,584
| New | +$196K |
|
207
Vanguard Morningstar Small-Cap Value ETF
VBR
$38B
| $200K | 0.06% |
+1,116
| New | +$198K |
|
|
MMAT
208
DELISTED
Meta Materials Inc. Common Stock
MMAT
| $49K | 0.01% |
200
| – | – |
|
|
209
Medtronic
MDT
$116B
| – | – |
-2,016
| Closed | -$253K |
|
210
Valero Energy
VLO
$93.3B
| – | – |
-3,150
| Closed | -$222K |
|
|
COR
211
DELISTED
Coresite Realty Corporation
COR
| – | – |
-12,450
| Closed | -$1.73M |
|
Similar funds
PCM
PFBT
SP
HCS
SPC
GPCM
MCM
CC
Journey Advisory Group's Q4 2021 Portfolio in Review
As of Q4 2021, Journey Advisory Group held 211 positions worth $362M, up 17% from $309M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Journey Advisory Group deployed $21.6M of net new capital in Q4 2021, opening 15 new positions and adding to 113 existing holdings. Its largest new stake was Goldman Sachs: 1,686 shares worth $645K.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Staples.
On the sell side, the largest reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $834K trimmed.
- Journey Advisory Group's largest Q4 2021 buy was Goldman Sachs: 1,686 shares worth $645K.
- Journey Advisory Group added most to Microsoft in Q4 2021, an estimated $2.57M increase.
- Journey Advisory Group's biggest Q4 2021 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $834K.
- Journey Advisory Group fully exited Coresite Realty Corporation in Q4 2021, selling an estimated $1.73M.
- Journey Advisory Group's ten largest holdings make up 36% of its $362M portfolio in Q4 2021.
- Journey Advisory Group opened 15 new positions and closed 3 in Q4 2021.
- Journey Advisory Group's portfolio value rose 17% quarter-over-quarter to $362M.
Based on Journey Advisory Group's 13F filing for Q4 2021, filed 11 Feb 2022.